The expression of lncRNA Blnc1 in the blood of DN patients and rats is improved, and inactivation of lncRNA Blnc1 can aggravate adipose tissue inflammation and fibrosis, insulin resistance and hepatic steatosis. This evidence concerns the gene PAQR9 and fatty liver disease.